YB1 is a negative regulator in liver fibrosis. We wondered whether SJYB1, a homologous protein of YB1 from Schistosoma japonicum, has an effect on liver fibrosis in vitro. Recombinant SJYB1 (rSJYB1) protein was expressed in a bacterial system and purified by Ni-NTA His·Bind Resin. A human hepatic stellate cell line, the LX-2 cell line, was cultured and treated with rSJYB1. The role of rSJYB1 on LX-2 cells was then analysed by Western blot and luciferase assay. We succeeded in expressing and purifying SJYB1 in a bacterial system and the purified rSJYB1 could be recognized by S japonicum-infected rabbit sera. Western bolt analysis showed that rSJYB1 inhibited the expression of collagen type I, but had little effect on α-smooth muscle actin (α-SMA). Further analysis revealed that rSJYB1 inhibited the activity of collagen α1 (I) (COL1A1) promoter and functioned at −1592/−1176 region of COL1A1 promoter.
| INTRODUC TI ON
Liver fibrosis is a pathological process characterized by accumula- inhibiting transforming growth factor-β (TGF-β) signalling, a major pathway to initiate HSC activation. 2 Overexpression of YB1 can partially rescue tissue in a CCl 4 -induced liver damage model 3 and this beneficial effect is linked with the repressive effect of YB1 on collagen type I gene transcription. 4 Furthermore, it is reported that a novel small compound Hsc025 ameliorates CCl 4 -induced liver fibrosis in mice by promoting nuclear translocation of YB1 and subsequently inhibiting TGF-β-stimulated collagen gene expression. 5 In this study, we expressed and purified a YB1 homologue, the recombinant SJYB1 protein (rSJYB1) from Schistosoma japonicum (S japonicum) in a bacterial system. Results from this study demonstrated that rSJYB1 inhibits collagen type I protein expression in HSCs via down-regulating activity of collagen α1 (I) (COL1A1) promoter. 
| MATERIAL S AND ME THODS

| Reagents
| Amplification of SJYB1
Based on the nucleotide sequence of SJYB1 (NCBI Accssion No.
AF367371), two primers were designed to amplify SJYB1 from S japonicum egg cDNA (Table 1) . PCR parameters were as follows:
denaturation at 98°C for 10 seconds, primer annealing at 58°C
for 5 seconds, primer extension at 72°C for 1 minute, cycled for 30 cycles, with a final extension at 72°C for 10 minutes before storing the sample at 4°C. The PCR product was sequenced and the sequence was characterized using nucleotide basic local alignment search tool (https://blast.ncbi.nlm.nih.gov/Blast.cgi) and named SJYB1.
| Construction of SJYB1 prokaryotic expression vector
PCR products of SJYB1 were digested with BamHI and HindIII enzymes and ligated to BamHI-and HindIII-digested expression vector pET28a (+). Insert DNA was sequenced to ensure authenticity of the clone nucleotide sequence.
| Expression and purification of rSJYB1
The empty pET28a (+) vector or the recombinant construct of SJYB1 Western bolt analysis, the endotoxin in rSJYB1 was removed using polymyxin B-agarose beads (Sigma, Saint Louis, MO, USA) following the suggested protocol. The removal of endotoxins in the protein was verified using the ToxinSensor TM chromogenic limulus amebocyte lysate endotoxin assay kit (GenScript, Nanjing, Jiangsu, China).
| Infection sera
New Zealand white rabbits were percutaneously infected with 200 cercariae and the sera were collected 45 days pi. Animal welfare and experimental procedures were carried out in accordance with the 
TA B L E 1 Primers used in this study
| Cell culture
The LX-2 cells were purchased from the XiangYa Central Experiment Laboratory (China). Cells were cultured in DMEM (Gibco, Waltham, MA, USA), supplemented with 10% foetal bovine serum (Thermo, Waltham, MA, USA) at 37°C with 5% CO 2 in a humidified incubator.
| Western blot analysis
Cells were lysed in radio-immunoprecipitation assay buffer with 1% phenylmethanesulfonyl fluoride (PMSF) (Biosharp) and phosphatase inhibitor complex III (1 mmol/L) (Sangon Biotech, Shanghai, China).
Equal amounts of protein extracts were separated by 8% sodium dodecyl SDS-PAGE and then transferred onto polyvinylidene difluoride 
| Construction of plasmids containing COL1A1 promoter sequence
Genomic DNA was extracted from LX-2 cells according to instructions for QIAamp® DNA Micro Kit (Qiagen, Hilden, Germany) and used as a template. For generating the COL1A1 promoter construct (pGL3-COL1A1), a 1744 bp fragment containing the sequences from −1722 to +22 of human COL1A1 promoter was amplified by PCR from genomic DNA. The primers were designed according to the genomic sequence of human chromosome 17 (GenBank accession no. NC000017.11) for COL1A1 ( Table 1 ). The PCR products were digested with SacI and XhoI and then subcloned into pGL3-basic vector (Promega, Madison, WI, USA). To construct the COL1A1
promoter-associated truncated plasmids, the indicated fragments were amplified by PCR from pGL3-COL1A1 and PCR primers were designed as shown in Table 1 . The PCR products were also digested with SacI and XhoI and then subcloned into pGL3-basic vector. S japonicum. Sera from uninfected rabbits and protein sample from empty pET28a (+) vector were used as negative controls. The results showed that rSJYB1 was recognized strongly by S japonicuminfected rabbit sera ( Figure 1B ). In contrast, sera from uninfected rabbits could not recognize rSJYB1 ( Figure 1C ) and neither S japonicum-infected rabbit sera nor uninfected rabbit sera could recognize protein sample from empty pET28a (+) vector ( Figure 1B,C) . These results indicated that native SJYB1 induces circulating antibodies in rabbits during S japonicum infection.
| Transfection and dual-luciferase reporter assay
| rSJYB1 inhibits collagen type I expression in LX-2 cells
To determine the effect of rSJYB1 on liver fibrosis in vitro, we used a human HSC line, LX-2 cells, to examine the protein expression of α-SMA and collagen type I, the former being the marker of activated HSCs and the latter the major component of ECM. As shown in Figure 2A , LX-2 cells were treated with 2.5 μg/mL rSJYB1 for different times, and the expression of collagen type I was noticeably reduced after 72 hours. Unexpectedly, rSJYB1 had little effect on the expression of α-SMA after 48 or 72 hours. We also measured the levels of collagen type I and α-SMA in LX-2 cells exposed to rSJYB1 at various concentrations (0, 1.25, 2.5 and 5 μg/mL) for 72 hours. The data revealed that treatment with rSJYB1 at 2.5 μg/mL resulted in an obvious decrease in the expression of collagen type I ( Figure 2B ), whereas no dose of rSJYB1 had an effect on α-SMA expression. These results suggested that rSJYB1 is specifically involved in regulation of collagen type I expression to exert anti-fibrotic action in LX-2 cells.
| rSJYB1 inhibits COL1A1 promoter activity in LX-2 cells
Next, to examine whether the effect of rSJYB1 on collagen type I expression takes place at the transcriptional level, we constructed a luciferase reporter plasmid of COL1A1 promoter, pGL3-COL1A1.
In our reporter assays, pGL3-COL1A1 had markedly higher activity compared to pGL3-basic in LX-2 cells (Figure 3 ). However, its activity was decreased after treatment with rSJYB1 for 72 hours (Figure 3 ).
These results showed that rSJYB1 has a crucial role in the regulation of COL1A1 promoter activity.
| rSJYB1 functions at −1592/−1176 region of COL1A1 promoter to inhibit its activity
In order to narrow down the activity region, we established five luciferase reporter plasmids of truncated fragments of COL1A1
promoter, named pGL3-COL1A1a, pGL3-COL1A1b, pGL3-COL1A1c, pGL3-COL1A1d and pGL3-COL1A1e ( Figure 4A ). The activities of these truncated fragments of COL1A1 promoter were shown in Figure 4B . Next, these truncated fragments of COL1A1
promoter as well as pGL3-COL1A1 were transfected into LX-2 cells, respectively, and then, transfected cells were treated with rSJYB1 for 72 hours. Results from reporter assays indicated that COL1A1 promoter activity was apparently decreased in rSJYB1-treated LX-2 cells transfected with pGL3-COL1A1 and pGL3-COL1A1a, while rSJYB1 had little effect on activities of other truncated fragments of COL1A1 promoter ( Figure 4C ). These results suggest that rSJYB1 functions at −1592/−1176 region of COL1A1 promoter to inhibit its activity. ) were left unstimulated or stimulated with several doses of rSJYB1, and then, immunoblot analysis was performed with the indicated Abs. The histograms show the relative intensities of the bands, which were quantitated by densitometry using Image Lab and normalized to GAPDH levels. Graphs show mean ± SD, n = 3. **P < 0.01
| D ISCUSS I ON
The YB1 proteins were first recognized as transcriptional factors binding to the Y-box element. However, it has since become apparent that the YB1 proteins are multifunctional and participate in translational regulation, DNA repair and pre-mRNA splicing 6 Extensive studies have shown that the YB1 proteins are related to proliferation and transformation of eukaryotic cells, 7, 8 being also correlated with tumour aggressiveness and as a promising molecular target in the therapy of cancer and inflammation. 9 A schistosome YB1 protein SMYB1 was earlier identified by Franco et al who isolated from an Schistosoma mansoni (S mansoni) adult worm library using the expressed sequence tag strategy. 10 SMYB1 has been verified the ability to bind DNA and RNA like other Y-box proteins and may act in the process of RNA metabolism. 11, 12 Furthermore, mice immunized with the recombinant SMYB1 (rSMYB1) were detected the high levels of specific anti-rSMYB1 antibodies in their sera.
13
SJYB1 reported in our study shares 83.33% identity in its nucleotide sequence and 94.47% in its protein sequence with SMYB1
(data not shown). Recombinant SJYB1 was strongly recognized by S japonicum-infected rabbit sera, suggesting that native SJYB1 can induce circulating antibodies in rabbits during S japonicum infection.
Therefore, these results indicated that recombinant and native YB1 from schistosomes both have high immunogenicity.
Infection with S japonicum can lead to hepatic schistosomiasis, and the main pathologic lesions of hepatic schistosomiasis are granuloma formation and liver fibrosis around schistosome eggs.
14 Schistosome eggs are an important source of antigens, which result in hepatic schistosomiasis. 15 Nevertheless, Anthony et al reported that schistosome eggs inhibit HSC fibrogenesis in vitro, with downregulation of α-SMA and collagen type I 16, 17 Our previous studies also found that soluble egg antigen (SEA), secreted by schistosome eggs, is engaged in anti-fibrotic activity. [18] [19] [20] [21] Furthermore, it is demonstrated that P40, a major component of SEA, limits HSC activation via inhibiting TGF-β signalling to modulate liver fibrosis in vitro. 22 However, the results of the current study suggested that the effect of rSJYB1 on HSCs differs from SEA and P40. Recombinant Twenty-four hours after transfection, cells were left unstimulated or stimulated with rSJYB1 (2.5 μg/mL) for 72 h before luciferase assays were performed. The Graph shows mean ± SD, n = 3. *P < 0.05, ***P < 0.001 were transfected with the empty pGL3-basic vector, pGL3-COL1A1, pGL3-COL1A1a, pGL3-COL1A1b, pGL3-COL1A1c, pGL3-COL1A1d or pGL3-COL1A1e reporter plasmid (1 μg) and pRL-TK reporter plasmid (0.02 μg). Twenty-four hours after transfection, cells were left unstimulated or stimulated with rSJYB1 (2.5 μg/mL) for 72 h before luciferase assays were performed. The graph shows mean ± SD, n = 3. **P < 0.01 SJYB1 inhibited the expression of collagen type I, but not α-SMA in LX-2 cells, suggesting that rSJYB1 specifically regulates synthesis of collagen type I rather than HSC activation. Unexpectedly, another study on mice infected with S mansoni has revealed that infected mice immunized with rSMYB1 exhibited reductions in the number of adult worm and eggs/granuloma retained in the liver, but no significant decrease was detected in the area of fibrosis. 13 It is possible that the roles of YB1 from schistosomes in vitro are not entirely consistent with that in vivo. In addition, whether the minor differences in protein sequences lead to the function difference between SJYB1
and SMYB1 has not been determined. Furthermore, it is demonstrated that SMYB1 could not bind to promoters of the S mansoni genes in vivo indicating that SMYB1 may not act directly as a transcription factor.
11
Therefore, it is possible that rSJYB1 regulates COL1A1 promoter activity indirectly, which may be via relevant transcription factors or signalling pathways, just as P40 regulates p27 promoter activity via transcription factor E2F1. 24 Further studies will be performed to elucidate the molecular mechanism.
In conclusion, our data suggest that rSJYB1-mediated anti-fibrotic activity involves inhibiting the activity of COL1A1 promoter and subsequently suppressing the expression of collagen type I in HSCs. 
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